Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 16,641–16,660 of 23,259 recalls

FDA Recall United States Terminated Historical recordClass II

Whiskey Hill Smokehouse

Product
Elk Jerky, brand Trophy Series, heat treated shelf stable pa…
Reason
Elk jerky is recalled due to undeclared soy lecithin.
Published
April 26, 2017
Distribution
CA, FL, IL, MA, NC, NY, OR, OR, PA, TX,…

View recall →

FDA Recall United States Terminated Historical recordClass II

Whiskey Hill Smokehouse

Product
Bison Jerky, brand Trophy Series, heat treated shelf stable…
Reason
Bison jerky is recalled due to undeclared soy lecithin.
Published
April 26, 2017
Distribution
CA, FL, IL, MA, NC, NY, OR, OR, PA, TX,…

View recall →

FDA Recall United States Terminated Historical recordClass II

Whiskey Hill Smokehouse

Product
Venison Jerky, brand Trophy Series, heat treated shelf stabl…
Reason
Venison jerky is recalled due to undeclared soy lecithin.
Published
April 26, 2017
Distribution
CA, FL, IL, MA, NC, NY, OR, OR, PA, TX,…

View recall →

FDA Recall United States Terminated Historical recordClass I

Pondini, inc.

Product
Pecorino Balze Volteranne DOP Societa Agricola Fattoria Li…
Reason
Pecorino Balze Volteranne raw sheeps milk cheese tested positive for Listeria monocytogenes
Published
April 26, 2017
Distribution
NJ and NY

View recall →

FDA Recall United States Terminated Historical recordClass I

Advanced Fresh Concepts Corp

Product
AFC Edamame Soybeans in Pods, 8 oz , refrigerated, in cardbo…
Reason
Product may be contaminated with listeria monocytogenes
Published
April 26, 2017
Distribution
The products were packaged by AFC Franch…

View recall →

FDA Recall Terminated Historical recordClass III

BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, packaged in a) 60-count bottles (NDC 59746-317-60) and b) 100-count bottles (NDC 59746-317-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottles (NDC 59746-316-60) and b) 100-count bottles (NDC 59746-316-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDC 59746-315-60) and b) 100-count bottles (NDC 59746-315-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.

by Mckesson Medical Surgical

Reason
Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.

by Allergan Sales, LLC

Reason
Failed Impurities/Degradation Specifications
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles, Packed by MEDISCA INC. PLATTSBURGH, NY Product Code 2261

by Medisca, Inc.

Reason
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b) 1 g (NDC 38779-0869-06), c) 5 g (NDC 38779-0869-03), d) 10 g (NDC 38779-0869-01), e) 25 g (NDC 38779-0869-04), f) 100 g (NDC 38779-0869-05) , g) 500 g (NDC 38779-0869-08), h) 1 Kg (NDC 38779-0869-09) bottles, Packed by MEDISCA INC. PLATTSBURGH, NY 12901; Product Code 0869

by Medisca, Inc.

Reason
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-06), c) 5 grams (NDC 38779-0891-03), d) 25 grams (NDC 38779-0891-04), and e) 100 grams (NDC 38779-0891-09) Bottles, Packed by MEDISCA INC. PLATTSBURGH, NY 12901; Product Code 0891

by Medisca, Inc.

Reason
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 grams (NDC 38779-0732-04) , c) 100 grams (NDC 38779-0732-05), and d) 1 Kg (NDC 38779-0732-09) bottles, Packed by MEDISCA, INC. PLATTSBURGH, NY 12901; Product Code 0732

by Medisca, Inc.

Reason
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Double Hyaluronic 1000, 'AN OUNCE OF GOLD' Volumizing Day Cream, Broad Spectrum SPF 30+, (Octinoxate 7.725%, Oxybenzone 6.18%, Octisalate 5.15%, Avobenzone 3.09%), Net Wt. 1.8 oz. (51 g) jar, Distributed by Signature Club A, Ltd, Tampa, FL 33609.

by Signature Club A Ltd

Reason
Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-625-12

by Akorn, Inc.

Reason
Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.
Published
April 19, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-012-01),

by Qinhuangdao Zizhu Pharmaceutical, Co.

Reason
cGMP Deviations; lack of quality assurance.
Published
April 19, 2017
Distribution
Product distributed to NY, TX, SC, CO, M…

View recall →

FDA Recall Terminated Historical recordClass II

Ethinyl Estradiol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China (NDC 44132-002-05)

by Qinhuangdao Zizhu Pharmaceutical, Co.

Reason
cGMP Deviations; lack of quality assurance.
Published
April 19, 2017
Distribution
Product distributed to NY, TX, SC, CO, M…

View recall →

FDA Recall Terminated Historical recordClass II

Testosterone Micronized, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-006-06)

by Qinhuangdao Zizhu Pharmaceutical, Co.

Reason
cGMP Deviations; lack of quality assurance.
Published
April 19, 2017
Distribution
Product distributed to NY, TX, SC, CO, M…

View recall →

FDA Recall Terminated Historical recordClass II

Estrone Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-003-04) (NDC 44132-003-02)(NDC 44132-003-06)

by Qinhuangdao Zizhu Pharmaceutical, Co.

Reason
cGMP Deviations; lack of quality assurance.
Published
April 19, 2017
Distribution
Product distributed to NY, TX, SC, CO, M…

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.